John Paulson’s Labcorp LH Stock Holding History

John Paulson’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-27,470	Closed	-$2.92M	–	101
2015 Q4	$2.92M	Buy	+27,470	New	+$2.83M	0.02%	65

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

John Paulson's LH Position: Q1 2016 in Review

John Paulson sold out of Labcorp (LH) in Q1 2016, closing a stake of 27,470 shares — an estimated $2.92M sold.

John Paulson first reported a position in LH in Q4 2015 and held it in 1 quarter. The position peaked at $2.92M in Q4 2015. 631 funds tracked by Wall St. Rank hold LH as of Q1 2016.

John Paulson reported no remaining Labcorp position as of Q1 2016 after selling out during the quarter.
John Paulson sold 27,470 Labcorp shares in Q1 2016, an estimated $2.92M.
John Paulson first reported a position in Labcorp in Q4 2015 and held it in 1 quarter.
John Paulson's Labcorp position peaked at $2.92M in Q4 2015.
631 funds tracked by Wall St. Rank held Labcorp as of Q1 2016.

Based on Paulson & Co's 13F filing for Q1 2016, filed 16 May 2016.